SC
CLOV icon

Sapient Capital’s Clover Health Investments CLOV Stock Holding History

Sapient Capital’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-80,000
Closed -$141K – 412
2026
Q1 		$141K Buy
+80,000
New +$174K ﹤0.01% 434

Other funds holding CLOV

FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
SWM
SeaCrest Wealth Management Purchase, New York $903M AUM 47.26% 1-Year Est. Return
SCP
Silverleafe Capital Partners Germantown, Tennessee $367M AUM 37.49% 1-Year Est. Return
RA
RFG Advisory Birmingham, Alabama $6.4B AUM 19.93% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
CMA
Cedar Mountain Advisors Lake Oswego, Oregon $581M AUM 18.16% 1-Year Est. Return
SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Sapient Capital's CLOV Position: Q2 2026 in Review

Sapient Capital sold out of Clover Health Investments (CLOV) in Q2 2026, closing a stake of 80,000 shares — an estimated $141K sold.

Sapient Capital first reported a position in CLOV in Q1 2026 and held it in 1 quarter. The position peaked at $141K in Q1 2026. 11 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • Sapient Capital reported no remaining Clover Health Investments position as of Q2 2026 after selling out during the quarter.
  • Sapient Capital sold 80,000 Clover Health Investments shares in Q2 2026, an estimated $141K.
  • Sapient Capital first reported a position in Clover Health Investments in Q1 2026 and held it in 1 quarter.
  • Sapient Capital's Clover Health Investments position peaked at $141K in Q1 2026.
  • 11 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on Sapient Capital's 13F filing for Q2 2026, filed 9 Jul 2026.